Is Bristol-Myers Squibb Co halal to invest in?

According to Musaffa's Shariah screening methodology, Bristol-Myers Squibb Co (BMY) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Bristol-Myers Squibb Co a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Bristol-Myers Squibb Co using these criteria to determine its compliance status.

Can Muslims buy shares of Bristol-Myers Squibb Co?

Muslim investors may consider investing in Bristol-Myers Squibb Co if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Bristol-Myers Squibb Co classified as NOT HALAL?

Musaffa determines the Shariah status of Bristol-Myers Squibb Co by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Bristol-Myers Squibb Co updated?

The Shariah compliance status of Bristol-Myers Squibb Co may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Bristol-Myers Squibb Co become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Bristol-Myers Squibb Co?

You can check the latest Shariah compliance status of Bristol-Myers Squibb Co on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BMY Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: May 04, 2026

Report Source: 2026 1st Quarter Report

Bristol-Myers Squibb Co. Stock Analysis BMY

United States Health Care Large Cap Report: Q1, 2026

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company is headquartered in Princeton, New Jersey and currently employs 32,500 full-time employees. The company is engaged in the discovery, development, and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Orencia (abatacept), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Breyanzi (lisocabtagene maraleucel), Opdualag (nivolumab and relatlimab-rmbw), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), Sotyktu (deucravacitinib), Krazati (adagrasib), and Cobenfy (xanomeline and trospium chloride). Its other growth products include Augtyro, Onureg, Inrebic, Nulojix, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension).

Key Statistics of Bristol-Myers Squibb Co (BMY)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$56.14$57.11

Today's Open

$56.64

Volume

10.82M

P/E Ratio (TTM)

3,168.93

52 Week Range

$42.52$62.89

Market Cap

116.24B

Avg. Volume

10.06M

Dividend Yield

2.12%

Financial Metrics & Statements of Bristol-Myers Squibb Co (BMY)

FAQ's for Bristol-Myers Squibb Co (BMY)

According to Musaffa’s Shariah screening methodology, Bristol-Myers Squibb Co (BMY) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.